I was not trying to analyze the stock. I have always believed that it does not deserve the sky high PE. Now as well as in the past. What I do know from first-hand experience is for a B2C company, consistent quality of all its products, especially when they are sold under the flagship brand name, is paramount to its survival and growth. The % share of a product in total sales is irrelevant.
As far as Caratlane purchase consideration goes, my comment is, shareholders and the market gives a long rope to its darlings. How many minority shareholders go through the trouble of voting on resolutions?
| Subscribe To Our Free Newsletter |
